SAN FRANCISCO – In another major deal on the opening day of the 33rd Annual J.P. Morgan (JPM) Healthcare Conference, Roche AG revealed that it is acquiring a majority ownership in Foundation Medicine Inc. (FMI) in a transaction valued at up to $1.05 billion.